Faculty profile

Julianna Blagih

ResearcherObstetrics and GynecologyUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Julianna Blagih

Researcher

Obstetrics and Gynecology

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
8 publications in the last five years, latest in 2026.
Principal investigator on 5 research grants (3 CIHR, 2 NSERC), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cellular Metabolism Cd8 T Cells Differentiation Epigenetic Evironmental Exposures Listeria Monocytogenes Metabolomics Mitochondria

Latest papers

Sucralose as a Way to Enhance Regulatory T Cells, the SWEET Trial: Clinical Research Protocol.
Canadian journal of kidney health and disease · 2026
Canagliflozin synergises with serine restriction mediating anti-leukaemic effects in T-cell acute lymphoblastic leukaemia.
Molecular metabolism · 2025
Mitochondrial ABHD11 inhibition drives sterol metabolism to modulate T-cell effector function.
Nature communications · 2025

All 17 publications

Latest funding

Environmental vulnerabilities of CD8 T cell responses
CIHR · 2025 · Nominated PI
$1,032,750
When sweet is too sweet: The impact of artificial sweeteners on postpartum breast cancer
CIHR · 2025 · Nominated PI
$67,500
Dissecting the diet-dependent immune-mediated potentiation of radiotherapy in prostate cancer
CIHR · 2025 · Nominated PI
$1,296,675

All 9 grants and awards

17 publications.

Sucralose as a Way to Enhance Regulatory T Cells, the SWEET Trial: Clinical Research Protocol.

Bourguignon L, Benazzouk Y, Bokou-Gianneli E, Zani F, Blagih J, Lamarche C

Canadian journal of kidney health and disease2026

DOI: 10.1177/20543581261418540 PMID: 41694241

Canagliflozin synergises with serine restriction mediating anti-leukaemic effects in T-cell acute lymphoblastic leukaemia.

Ponce-Garcia FM, Jenkins YR, Assmann VD, Paul S, Sharma ND, Moore C, Ma EH, Diamanti P, Hennequart M, Blagih J, Le L, Jenkins BJ, Rouvray S, Cronin JG, Jones RG, Mansour M, Blair A, Halsey C, Matlawska-Wasowska K, Herranz D, Vincent EE, Jones N

Molecular metabolism2025

DOI: 10.1016/j.molmet.2025.102275 PMID: 41120088

Mitochondrial ABHD11 inhibition drives sterol metabolism to modulate T-cell effector function.

Jenkins BJ, Jenkins YR, Ponce-Garcia FM, Moscrop C, Perry IA, Hitchings MD, Uribe AH, Bernuzzi F, Eastham S, Cronin JG, Berisha A, Howell A, Davies J, Blagih J, Williams M, Marsden M, Veale DJ, Davies LC, Niphakis M, Finlay DK, Sinclair LV, Cravatt BF, Hogan AE, Nathan JA, Humphreys IR, Fearon U, Sumpton D, Vande Voorde J, Vale GDD, McDonald JG, Jones GW, Pearson JA, Vincent EE, Jones N

Nature communications2025

DOI: 10.1038/s41467-025-65417-4 PMID: 41184294

ABHD11 inhibition drives sterol metabolism to modulate T cell effector function and alleviate autoimmunity.

Jenkins BJ, Jenkins YR, Ponce-Garcia FM, Moscrop C, Perry IA, Hitchings MD, Uribe AH, Bernuzzi F, Eastham S, Cronin JG, Berisha A, Howell A, Davies J, Blagih J, Veale DJ, Davies LC, Niphakis M, Finlay DK, Sinclair LV, Cravatt BF, Hogan AE, Nathan JA, Fearon U, Sumpton D, Vande Voorde J, Dias do Vale G, McDonald JG, Jones GW, Pearson JA, Vincent EE, Jones N

bioRxiv : the preprint server for biology2025

DOI: 10.1101/2025.03.19.643996 PMID: 40166327

Loss of attachment promotes proline accumulation and excretion in cancer cells.

Pilley SE, Hennequart M, Vandekeere A, Blagih J, Legrave NM, Fendt SM, Vousden KH, Labuschagne CF

Science advances2023

DOI: 10.1126/sciadv.adh2023 PMID: 37672588

Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity.

Jenkins BJ, Blagih J, Ponce-Garcia FM, Canavan M, Gudgeon N, Eastham S, Hill D, Hanlon MM, Ma EH, Bishop EL, Rees A, Cronin JG, Jury EC, Dimeloe SK, Veale DJ, Thornton CA, Vousden KH, Finlay DK, Fearon U, Jones GW, Sinclair LV, Vincent EE, Jones N

Cell metabolism2023

DOI: 10.1016/j.cmet.2023.05.001 PMID: 37230079

ALDH1L2 regulation of formate, formyl-methionine, and ROS controls cancer cell migration and metastasis.

Hennequart M, Pilley SE, Labuschagne CF, Coomes J, Mervant L, Driscoll PC, Legrave NM, Lee Y, Kreuzaler P, Macintyre B, Panina Y, Blagih J, Stevenson D, Strathdee D, Schneider-Luftman D, Grönroos E, Cheung EC, Yuneva M, Swanton C, Vousden KH

Cell reports2023

DOI: 10.1016/j.celrep.2023.112562 PMID: 37245210

The dietary sweetener sucralose is a negative modulator of T cell-mediated responses.

Zani F, Blagih J, Gruber T, Buck MD, Jones N, Hennequart M, Newell CL, Pilley SE, Soro-Barrio P, Kelly G, Legrave NM, Cheung EC, Gilmore IS, Gould AP, Garcia-Caceres C, Vousden KH

Nature2023

DOI: 10.1038/s41586-023-05801-6 PMID: 36922598

Hypoxia-inducible factors in CD4+ T cells promote metabolism, switch cytokine secretion, and T cell help in humoral immunity.

Cho SH, Raybuck AL, Blagih J, Kemboi E, Haase VH, Jones RG, Boothby MR

Proceedings of the National Academy of Sciences of the United States of America2019

DOI: 10.1073/pnas.1811702116 PMID: 30988188

Mitochondrial cyclophilin D regulates T cell metabolic responses and disease tolerance to tuberculosis.

Tzelepis F, Blagih J, Khan N, Gillard J, Mendonca L, Roy DG, Ma EH, Joubert P, Jones RG, Divangahi M

Science immunology2018

DOI: 10.1126/sciimmunol.aar4135 PMID: 29752301

Environmental vulnerabilities of CD8 T cell responses

Nominated PICIHR2025Project Grant

Principal investigators: Blagih, Julianna

Keywords: Cd8 T Cells; Cellular Metabolism; Differentiation; Epigenetic; Evironmental Exposures; Listeria Monocytogenes; Metabolomics; Mitochondria; Sucralose; T Cell Memory

$1,032,750

When sweet is too sweet: The impact of artificial sweeteners on postpartum breast cancer

Nominated PICIHR2025CIHR-ICR / Cancer Research Society Partnership - Res. Gr. Cancer Prev.

Principal investigators: Blagih, Julianna

Keywords: Cancer

$67,500

Dissecting the diet-dependent immune-mediated potentiation of radiotherapy in prostate cancer

Nominated PICIHR2025Project Grant

Principal investigators: Blagih, Julianna; Labbé, David

Keywords: Adaptive Immunity; Anti-Tumour Immunity; Cellular Metabolism; Dietary Intervention; Immune Profiling; Immunotherapy; Mouse Models; Prostate Cancer; Radiotherapy; Tumour Immune Microenvironment

$1,296,675

Regulatory T cells (Tregs): a new therapeutic target for uremic cardiomyopathy?

Co-investigatorCIHR2025Project Grant

Principal investigators: Lamarche, Caroline

Keywords: Chronic Kidney Disease; Immunotherapy; Regulatory T Cells; Tregs; Uremic Cardiomyopathy; Uremic Toxins

$933,300

A histology suite for visualizing cell distribution in tissues

Co-investigatorNSERC2024Research Tools and Instruments

Principal investigators: Lesage, Sylvie

Keywords: Cellular positioning; Fluorecent microscopy; Histology; Microscopy; Tissue sections

$110,438

Defining the impact of genetic variation on the quality of the humoral response

Co-investigatorCIHR2023Project Grant - PA: Pandemic Preparedness and Health Emergencies Research

Principal investigators: Lesage, Sylvie

Keywords: Affinity Maturation; Antibody; Antigen Challenge; B Cell; Genetics; Germinal Center; Humoral Response; Mouse Models; T Cell; Vaccination

$100,000

Regulation of glycolysis in T cell metabolic reprogramming

Principal investigatorNSERC2023Discovery Launch Supplement

Principal investigators: Blagih, Julianna

$12,500

Deciphering the function of new corneal macrophages

Co-investigatorNSERC2023Alliance Grants

Principal investigators: Thanabalasuriar, Ajitha AT

Keywords: Cornea; immune cells; Macrophages; metabolism; Microscopy; tissue injury

$90,000

Regulation of glycolysis in T cell metabolic reprogramming

Principal investigatorNSERC2023Discovery Grants Program - Individual

Principal investigators: Blagih, Julianna

Keywords: cellular metabolism; enzymatic function; T cell activation; T cell function; T cell proliferation; TIGAR

$80,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Julianna Blagih

Research

Latest papers

Latest funding

Sucralose as a Way to Enhance Regulatory T Cells, the SWEET Trial: Clinical Research Protocol.

Canagliflozin synergises with serine restriction mediating anti-leukaemic effects in T-cell acute lymphoblastic leukaemia.

Mitochondrial ABHD11 inhibition drives sterol metabolism to modulate T-cell effector function.

ABHD11 inhibition drives sterol metabolism to modulate T cell effector function and alleviate autoimmunity.

Loss of attachment promotes proline accumulation and excretion in cancer cells.

Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity.

ALDH1L2 regulation of formate, formyl-methionine, and ROS controls cancer cell migration and metastasis.

The dietary sweetener sucralose is a negative modulator of T cell-mediated responses.

Hypoxia-inducible factors in CD4+ T cells promote metabolism, switch cytokine secretion, and T cell help in humoral immunity.

Mitochondrial cyclophilin D regulates T cell metabolic responses and disease tolerance to tuberculosis.

Environmental vulnerabilities of CD8 T cell responses

When sweet is too sweet: The impact of artificial sweeteners on postpartum breast cancer

Dissecting the diet-dependent immune-mediated potentiation of radiotherapy in prostate cancer

Regulatory T cells (Tregs): a new therapeutic target for uremic cardiomyopathy?

A histology suite for visualizing cell distribution in tissues

Defining the impact of genetic variation on the quality of the humoral response

Regulation of glycolysis in T cell metabolic reprogramming

Deciphering the function of new corneal macrophages

Regulation of glycolysis in T cell metabolic reprogramming

Frequent collaborators

Maziar Divangahi

Caroline Lamarche

Morag Park

Jerry Pelletier

Julie St-Pierre

Arnim Pause

Morag Park

Nahum Sonenberg

Philippe Joubert

Julianna Blagih

Research

Latest papers

Latest funding

Sucralose as a Way to Enhance Regulatory T Cells, the SWEET Trial: Clinical Research Protocol.

Canagliflozin synergises with serine restriction mediating anti-leukaemic effects in T-cell acute lymphoblastic leukaemia.

Mitochondrial ABHD11 inhibition drives sterol metabolism to modulate T-cell effector function.

ABHD11 inhibition drives sterol metabolism to modulate T cell effector function and alleviate autoimmunity.

Loss of attachment promotes proline accumulation and excretion in cancer cells.

Canagliflozin impairs T&#xa0;cell effector function via metabolic suppression in autoimmunity.

ALDH1L2 regulation of formate, formyl-methionine, and ROS controls cancer cell migration and metastasis.

The dietary sweetener sucralose is a negative modulator of T cell-mediated responses.

Hypoxia-inducible factors in CD4+ T cells promote metabolism, switch cytokine secretion, and T cell help in humoral immunity.

Mitochondrial cyclophilin D regulates T cell metabolic responses and disease tolerance to tuberculosis.

Environmental vulnerabilities of CD8 T cell responses

When sweet is too sweet: The impact of artificial sweeteners on postpartum breast cancer

Dissecting the diet-dependent immune-mediated potentiation of radiotherapy in prostate cancer

Regulatory T cells (Tregs): a new therapeutic target for uremic cardiomyopathy?

A histology suite for visualizing cell distribution in tissues

Defining the impact of genetic variation on the quality of the humoral response

Regulation of glycolysis in T cell metabolic reprogramming

Deciphering the function of new corneal macrophages

Regulation of glycolysis in T cell metabolic reprogramming

Frequent collaborators

Maziar Divangahi

Caroline Lamarche

Morag Park

Jerry Pelletier

Julie St-Pierre

Arnim Pause

Morag Park

Nahum Sonenberg

Philippe Joubert

Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity.